The KRASG12C inhibitors in lung cancer therapy
Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutation...
Saved in:
Main Authors: | Maciej Jędrak (Author), Karolina Niekurzak (Author), Joanna Kania (Author), Maciej Józefiak (Author), Piotr Sobkiewicz (Author), Krzysztof Kania (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich's Ataxia - Review
by: Krzysztof Kania, et al.
Published: (2023) -
Seborrheic dermatitis - pathogenesis, epidemiology and effective treatment - literature review
by: Piotr Sobkiewicz, et al.
Published: (2023) -
The role of glymphatic system in neurological diseases - literature review
by: Karolina Niekurzak, et al.
Published: (2023) -
Pruritus. Pathomechanism, management and novel treatment
by: Maciej Józefiak, et al.
Published: (2023) -
The Impact of Competitive Sports on the Mental Health of Young People
by: Maciej Józefiak, et al.
Published: (2024)